PROTALIX BIOTHERAPEUTICS INC's ticker is PLX and the CUSIP is 74365A309. A total of 35 filers reported holding PROTALIX BIOTHERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.20 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,652 | +204.3% | 2,200 | +266.7% | 0.00% | – |
Q2 2023 | $1,200 | -4.9% | 600 | -0.2% | 0.00% | – |
Q1 2023 | $1,262 | +84.2% | 601 | +20.2% | 0.00% | – |
Q4 2022 | $685 | -99.9% | 500 | -99.6% | 0.00% | -100.0% |
Q1 2021 | $545,000 | – | 122,184 | +122084.0% | 0.00% | – |
Q3 2020 | $0 | – | 100 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Spire Wealth Management | 148,800 | $158,000 | 0.00% |
MEITAV INVESTMENT HOUSE LTD | 244,332 | $257,000 | 0.00% |
Phoenix Holdings Ltd. | 244,113 | $259,000 | 0.00% |
IHT Wealth Management, LLC | 24,000 | $25,000 | 0.00% |
Psagot Value Holdings Ltd. / (Israel) | 6,000 | $6,000 | 0.00% |
Virtu Financial LLC | 15,199 | $16,000 | 0.00% |
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 41,574 | $44,000 | 0.00% |
Smith Salley Wealth Management | 12,048 | $13,000 | 0.00% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 28,790 | $31,000 | 0.00% |
BANK OF AMERICA CORP /DE/ | 5,153 | $5,000 | 0.00% |